Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-30
1999-01-26
Hendricks, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 530350, 530351, 435194, C12N 912, A61K 3816
Patent
active
058638911
ABSTRACT:
A chimeric toxin comprising protein fragments joined together by peptide bonds, the chimeric toxin comprising, in sequential order, beginning at the amino terminal end of the chimeric toxin,
(a) the enzymatically active Fragment A of diphtheria toxin,
(b) a first fragment including the cleavage domain 1.sub.1 adjacent the Fragment A of diphtheria toxin,
(c) a second fragment comprising at least a portion of the hydrophobic transmembrane region of Fragment B of diphtheria toxin, the second fragment having a deletion of at least 50 diphtheria toxin amino acid residues, the deletion being C-terminal to the portion of the transmembrane region, and the second fragment not including domain 1.sub.2, and
(d) a third fragment comprising a portion of a cell-specific polypeptide ligand, the portion including at least a portion of the binding domain of the polypeptide ligand, the portion of the binding domain being effective to cause the chimeric toxin to bind selectively to a predetermined class of cells to be attacked by the enzymatically active Fragment A.
REFERENCES:
patent: 4468382 (1984-08-01), Bacha
patent: 4675382 (1987-06-01), Murphy
patent: 4830962 (1989-05-01), Gelfand et al.
Edwards, et al., Mol. Cell Biol. 9(7):2860-67 (1989).
Lambotte, et al., J. Cell Biol. 87:837-40 (1980).
Colombatti, et al., J. Biol. Chem. 261(7):3030-35 (1986).
Greenfield, et al., PNAS USA 80:6853-57 (1983).
Boguet, et al., PNAS USA 73:4449-53 (1976).
Bacha, et al., J. Biol. Chem. 258(3):1565-70 (1983).
Cabiaux, et al., J. Biol. Chem. 264(9):4928-38 (1989).
Rappuoli, et al., J. Bacteriol. 153:1202-10 (1983).
Bacha, et al., J. Exp. Med. 167:612-22 (1988).
Williams, et al., in Protein Engineering 1:493-98 (1987).
Bishai, et al., J. Bacteriol. 169(4):1554-63 (1987).
D. Williams, et al., "Structure/Function Analysis of IL-2 Toxin," in Protein Society Meeting, Aug. 1989, Abstract T 71.
Greenfield, et al., Science 238:536-39 (1987).
Simpson, et al., Cell 29:469-473 (1982).
Costa et al., Journal of Bacteriology 148(1):124-130 (1981).
Murphy, "Seminars in Infectious Disease," vol. IV: Bacterial Vaccines, pp. 81-85 (1982).
Leong, et al.,Science 220:515-517 (1983).
Kaczorek, et al., Science 221:855-858 (1983).
Ratti, et al., Nucleic Acids Research 11:6589-6595 (1983).
Greenfield, et al., PNAS, 80:6853-6857 (1983).
Tweten, et al., J. Bacteriology, 156:680-685 (1983).
Murphy, Current Topics in Microbiology and Immunology, 118:235-251 (1985).
Zettlmeissl, et al., Gene 41:103-111 (1986).
Murphy, PNAS, 83:8258-8262 (1986).
Bishai, Journal of Bacteriology, 169:1554-1563 (1987).
Murphy, Clinical Research 35:609a (1987).
Murphy John R.
Williams Diane P.
Boston Medical Center Corporation
Hendricks Keith D.
LandOfFree
Chimeric toxins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric toxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric toxins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450453